(Q81205526)

English

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study

scientific article published on 01 November 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15622454%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15622454%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

based on heuristic

inferred from title

immunologic adjuvant

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15622454%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

C L Cooper

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15622454%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

H L Davis

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15622454%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

M L Morris

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15622454%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

S M Efler

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15622454%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

M Al Adhami

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15622454%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

A M Krieg

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15622454%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

J Heathcote

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15622454%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15622454%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Journal of Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15622454%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15622454%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15622454%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

693-701

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15622454%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

https://scigraph.springernature.com/pub.10.1007/s10875-004-6244-3

0 references

CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CpG DNA induces stronger immune responses with less toxicity than other adjuvants

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancing vaccines with immune stimulatory CpG DNA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B: an important public health issue

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B vaccination--United States, 1982-2002.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CpG motifs in bacterial DNA and their immune effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic T cells and viral hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical experience with hepatitis B vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intrahepatic T cells in hepatitis B: viral control versus liver cell injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination of healthy adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of Flt3 ligand as an adjuvant for hepatitis B vaccination of healthy adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CPG ODN allows lower dose of antigen against hepatitis B surface antigen in BALB/c mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A hepatitis B vaccine formulated with a novel adjuvant system

1 reference

https://pubmed.ncbi.nlm.nih.gov/15622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81205526&oldid=1985047029"